Financial Survey: Health Catalyst (HCAT) and Its Competitors

Health Catalyst (NASDAQ:HCAT) is one of 93 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Health Catalyst to related companies based on the strength of its earnings, profitability, institutional ownership, analyst recommendations, valuation, risk and dividends.

Institutional & Insider Ownership

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 42.3% of shares of all “Healthcare Technology” companies are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 16.0% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings for Health Catalyst and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1	5	2	0	2.12
Health Catalyst Competitors	446	1517	2724	88	2.51

Health Catalyst presently has a consensus price target of $2.01, suggesting a potential upside of 18.84%. As a group, “Healthcare Technology” companies have a potential upside of 40.17%. Given Health Catalyst’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst has less favorable growth aspects than its competitors.

Profitability

This table compares Health Catalyst and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Health Catalyst Competitors	-778.92%	-33.96%	-15.64%

Valuation and Earnings

This table compares Health Catalyst and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health Catalyst	$311.14 million	-$177.97 million	-0.46
Health Catalyst Competitors	$342.33 million	-$24.15 million	12.93

Health Catalyst’s competitors have higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Health Catalyst has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500. Comparatively, Health Catalyst’s competitors have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.

Summary

Health Catalyst competitors beat Health Catalyst on 7 of the 13 factors compared.

Health Catalyst Company Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.